Associate Professor of Urology, Ohio State University
Urology
Dr. Kamal S. Pohar, MD
|
|
Give Review
Kamal Pohar is an expert in the field of Urology. He over the years received 2 awards: "Regional Top Doctor" and "CMS Meaningful Use Stage 1 Certification". Kamal Pohar has written publications. He has 28 publications published with PubMed. The lastest publication is: 'Do amount of variant differentiation and mitotic rate in bladder cancer change with neoadjuvant chemotherapy?' He is registered with Medicare and accepts Medicare payments.
Publications
- Do amount of variant differentiation and mitotic rate in Bladder cancer change with neoadjuvant chemotherapy?
- Prediction of chemotherapeutic response in Bladder cancer using K-means clustering of dynamic contrast-enhanced (DCE)-MRI pharmacokinetic parameters.
- Improving Bladder Cancer Imaging Using 3-T Functional Dynamic Contrast-Enhanced Magnetic Resonance Imaging.
- Challenges in the pathological reporting of urothelial carcinoma involving prostatic transUrethral resection specimens within a single institution.
- Clinicopathologic characteristics and overall survival in patients with Bladder cancer involving the gastrointestinal tract.
- The anatomic extent and completeness of Pelvic lymphadenectomy is what matters.
- Urinary Bladder chondroma.
- Quality of Lymphadenectomy is Equivalent With Robotic and Open Cystectomy Using an Extended Template.
- Prostate-specific antigen response after definitive radiotherapy for Skene's gland adenocarcinoma resembling Prostate adenocarcinoma.
- How do commonly performed lymphadenectomy templates influence Bladder cancer nodal stage?
- Preoperative Hydronephrosis as an indicator of survival after radical cystectomy.
- Information seeking and satisfaction with physician-patient communication among prostate Cancer survivors.
- Results of retroperitoneal lymph node dissection for clinical stage I and II pure embryonal carcinoma of the testis.
- Impact of alterations affecting the p53 pathway in Bladder cancer on clinical outcome, assessed by conventional and array-based methods.
- When is partial ureterectomy acceptable for transitional-cell carcinoma of the ureter?
- p14ARF silencing by promoter hypermethylation mediates abnormal intracellular localization of MDM2.
- p63 expression profiles in human normal and tumor tissues.
- State-of-the-art surgical management of Testicular tumors.
- Kidney Cancer. Clinical practice guidelines in oncology.
- Tomatoes, lycopene and prostate Cancer: a clinician''s guide for counseling those at risk for prostate Cancer.
- Testicular Cancer. Clinical practice guidelines in oncology.
- Kidney Cancer. Clinical practice guidelines.
- Ras-MAPK pathway as a therapeutic target in cancer--emphasis on Bladder cancer.
- Inflammatory myofibroblastic tumor of epididymis: a case report and review of literature.
- Vesicoenteric, vesicoVaginal, vesicocutaneous fistula -an unusual complication with intravesical mitomycin.
- Management of the residual post-chemotherapy retroperitoneal mass in germ cell tumors.
- How close are we to establishing standards of lymphadenectomy for invasive Bladder cancer?
Schools
University of Alberta Faculty of Medicine And Dentistry
University Of Manitoba Faculty Of Medici
Memorial SloanKettering Cancer Center
University of Alberta
Procedures Preformed
- Cystectomy
- Cystourethroscopy and TransUrethral Resection of Bladder Neck
- Destruction or Excision of Vaginal Lesions
- Kidney and Ureter Removal
- View All
Conditions Treated
- Bladder Cancer
- Bladder Infection
- Bladder Stones
- Blood in Urine (Hematuria)
- View All
Doctors Specialties
- Urology
Accepted Insurances
Awards
- Regional Top Doctor
- CMS Meaningful Use Stage 1 Certification
Education
-
University of Alberta Faculty of Medicine
Hospital
-
Ohio State University Wexner Medical Center
Drug Facts
| NPI NUMBER | 1952350985 | |
| NPPES Provider LastName | POHAR | |
| NPPES Provider FirstName | KAMAL | |
| NPPES Provider ZIPCode | 432123153 | |
| NPPES Provider State | OH | |
| Specialty Description | Urology | |
| Total Claim Count | 100.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1952350985 |
| Last Name Of The Provider | POHAR |
| First Name Of The Provider | KAMAL |
| View All |
Similar Doctors
|
Dr. Bodo E. Knudsen, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
Dr. Christopher D. McClung, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Roy R. Brown Jr., MD |
|
Dr. Errol O. Singh, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Stuart L. Bowers, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeffrey D. Harbrecht, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Michael T. Gambla, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Frank P. Begun, MD |
|
|
Dr. Chad M. Gridley, MD |
|
|
Dr. Brent E. Carlyle, MD |